January 17, 2021 05:49 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Veteran actor Biswajit Chatterjee conferred Indian Personality of Year Award at 51st IFFI | Covid-19 vaccination drive: Serum Institute of India CEO Adar Poonawalla gets inoculated | Iranian film Bandar Band wins best film at 26th KIFF | Brisbane Test: India 62/2 at stumps on day 2, trail Australia by 307 runs | Actor Sudeep to be chief guest at IFFI opening ceremony

Delhi resident doctors prefer Covishield over indigenous Covaxin in Covid-19 vaccination drive

New Delhi/IBNS: Within hours after Prime Minister Narendra Modi launched the Covid-19 vaccination drive, the resident doctors of Delhi on Saturday preferred to be inoculated with Oxford vaccine, named Covishield in India, over the indigenous Covaxin.

Covid-19 vaccination drive starts in Assam

Guwahati/UNI: The Covid-19 vaccination drive started in Assam on Saturday along with other parts of the country.

PM Modi launches world's biggest Covid-19 vaccination drive in India

New Delhi/IBNS: Prime Minister Narendra Modi on Saturday launched the world's biggest Covid-19 vaccination drive in India, which is one of the worst Novel Coronavirus-hit countries.

PM Modi to launch pan India Covid-19 vaccination drive at 10:30 AM on Saturday

New Delhi/IBNS: Prime Minister Narendra Modi will launch the pan India rollout of COVID-19 vaccination drive on Jan 16 at 10:30 AM via video conferencing. 

PM Modi likely to inaugurate Coronavirus vaccination drive virtually on Jan 16

New Delhi/IBNS: Prime Minister Narendra Modi is likely to inaugurate the coronavirus vaccination drive virtually on January 16, said media reports.

Congress MP Manish Tewari questions roll out of Covaxin

New Delhi/IBNS: Congress leader Manish Tewari has raised questions over unavailability of options in choosing the Coronavirus vaccine, according to media reports.

Covid-19: Bharat Biotech rolls out India's indigenous vaccine Covaxin

Hyderabad/IBNS: A day after the Serum Institute of India (SII) rolled out its vaccine against Covid-19, the first batch of India's indigenous remedy Covaxin, made by Bharat Biotech, left Hyderabad for 11 cities on Wednesday morning, media reports said.

Covid vaccine recipients don't get to choose between two options for now: Centre

New Delhi/IBNS: The Indian government on Tuesday said that no recipient of Covid-19 vaccine gets to choose from the two candidates available in the country for emergency use.

Bharat Biotech announces completion of phase 3 clinical trials of Covid-19 vaccine

New Delhi/UNI: Bharat Biotech on Thursday announced that it has enrolled 25,800 volunteers for phase 3 clinical trials of its indigenously manufactured Covid-19 vaccine, 'Covaxin'.

Covid vaccines to rollout within 10 days from date of authorisation: Centre

New Delhi/IBNS: The Centre on Tuesday informed that Covid-19 vaccines will be ready for rollout in 10 days from the emergency use authorisation date based on feedback from the dry run.

Don't accuse us of inexperience, we are a global company: Bharat Biotech Chairman to critics of Covaxin

New Delhi/IBNS: Chairman of Bharat Biotech- whose coronavirus vaccine Covaxin has been permitted for "restricted use in an emergency situation in public interest"- on Monday hit out at its critics and said 'don't accuse us of inexperience.'

India registers 18,177 new Covid-19 cases in last 24 hours, 217 deaths

New Delhi/IBNS: India registered 18,177 fresh infections in the last 24 hours taking the total Coronavirus cases to 1,03,23,965 on Sunday, the Union Health Ministry data showed.

Serum Institute, Bharat Biotech get DCGI approval for emergency use of Covid-19 vaccines

New Delhi/IBNS: Two Covid-19 vaccine candidates-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-on Sunday received the approval of the Drugs Controller General of India (DCGI) for emergency use in India.

Two Covid-19 vaccine candidates await DCGI approval for emergency use in India

New Delhi/IBNS: Two Covid-19 vaccine candidates in India-Hyderabad-based Bharat Biotech's Covaxin and the Serum Institute of India's Covishield-now awaits the approval of the Drugs Controller General of India (DCGI) for emergency use after they have been cleared by the government-appointed panel.

Expert panel recommends approval for Bharat Biotech's Covaxin

New Delhi/IBNS: A government-appointed panel of experts on Saturday cleared  emergency use of indigenous COVID-19 vaccine Covaxin manufactured by Hyderabad-based Bharat Biotech, which will be sent for approval to the regulator Drugs Controller General of India (DCGI).